Qatari German Company for Medical Devices (Q.P.S.C.) (QGMD) Earnings Call Transcript & Summary

Hello, and welcome to Qatar German Medical. [Operator Instructions] There will be a question-and-answer session after the prepared remarks. Please be advised that this call is being recorded at the company's request. I will now turn over the call to Bobby.

Thank you. Hi. Hello. Good afternoon, everyone. This is Bobby Sarkar, Head of Research at QNB Financial Services. I wanted to welcome everyone to Qatar German Medical Devices Second Quarter and 6 Months 2026 Results Conference Call. On this call from QGMD, we have Abdulaziz Saad Al-Tamimi, who is the Managing Director, and we will conduct this conference with management first reviewing the company's results followed by Q&A. I would now like to turn the call over to Abdulaziz. Sir, please go ahead.

Thank you and good afternoon to our investors and our shareholders. Qatari German Medical discloses the financial statement for the 6 months ended 30 June 2026. The financial statement declared a net loss of QAR 1.2 million in the comparison of -- to net profit, QAR 5.7 million for the same period of the previous year. The loss per share amounted to QAR 0.011 as of 30 June 2026 with earnings per share, QAR 0.05 for the same period in 2025. We are pleased to present the company financial results for the first half of 2026 ending June 30, 2026. The result reflected a significant improvement in operational and financial performance comparing to the same period in 2025. The company achieved sales of QAR 2.7 million compared to QAR 1.7 million during the same period in 2025, representing an increase approximately positive 54.8%. This growth reflects the company's ongoing efforts to enhance sales activity. The improvement in profitability is even more [indiscernible] earnings before interest, taxes and depreciation, EBITDA, excluding extraordinary revenue and expenses reached QAR 1.3 million during the first half of 2026 compared to QAR 64,000 in the same period 2025. This represents a significant progress in core operating performance. The company performance is at a positive impact of measures taken to improve operational efficiency, managing -- manage costs and optimize the use of existing resource and facility. Furthermore, the company is allocating a portion of the cash flow generated from this improved in the operational performance to repay and settle outstanding debt and obligations. This will contribute to easing financial burden, improving the company's financial position and enhances its ability to meet existing commitments. The company attain its commitment to maintaining this positive momentum throughout the remainder of 2026. It will continue to focus revenue growth operational efficiency, cost optimization, internal controls and governance and expanding its business activity to establish a stronger and more sustainable financial position in the future. This is all from my end.

Okay. Operator, can we open it up to questions?